A Single-centre, Single-blind, Randomised, Placebo-controlled Phase IIa Study to Investigate the Effect of AZD1305 Given as an Intravenous (iv) Infusion on Left Ventricular Performance in Patients With Left Ventricular Dysfunction.
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2011
At a glance
- Drugs AZD 1305 (Primary)
- Indications Left ventricular dysfunction
- Focus Therapeutic Use
- 02 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 May 2009 Planned end date changed from 1 Jun 2009 to 1 Jul 2009 as reported by ClinicalTrials.gov.